Keeping operational in COVID: pandemic planning and resilience

The challenges of running a start-up through a pandemic: Hiring

The Role of Public-Private Partnerships in the Future of Fusion Energy

MicrofluidX raises £1.4m in seed funding to develop novel cell therapy bioprocessing technology

New analysis confirms value of UKI2S investing public money to commercialise public science

Corporate communications in the COVID-19 crisis

How to build a start-up: Launching early stage science companies

UKI2S, Catapult Ventures and Jonathan Milner invest £500K in gene modulation newcomer Pencil Biosciences

Spin out secures £1.1M for ground-breaking ‘supercharged’ cell therapies to treat solid tumours

Rapid test for gonorrhoea and chlamydia to be developed by University of Birmingham spinout

Expert Interview with Gilad Gershon: Selecting the right talent for your start-up